Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 4/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.63 |
| ▸ | DPP4 | P27487 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21351801 | 0.98 | SLC6A4 (0.61) | SLC6A4SLC6A2SLC6A3DPP4MAOA | |
| SCHEMBL9330358 | 0.98 | DPP4 (0.63) | SLC6A4SLC6A2SLC6A3DPP4MAOA | |
| SCHEMBL10606137 | 0.93 | DPP4 (0.57) | SLC6A4SLC6A2SLC6A3DPP4MAOA | |
| SCHEMBL15955086 | 0.89 | MAOA (0.60) | SLC6A4SLC6A2SLC6A3DPP4MAOA | |
| SCHEMBL2089640 | 0.83 | SLC6A4 (0.59) | SLC6A4SLC6A2SLC6A3DPP4MAOA | |
| SCHEMBL15568275 | 0.80 | SLC6A4 (0.56) | SLC6A4SLC6A2SLC6A3DPP4CHRM2 | |
| SCHEMBL19123555 | 0.80 | SLC6A4 (0.50) | SLC6A4SLC6A2SLC6A3DPP4CHRM2 | |
| SCHEMBL14513169 | 0.79 | ALDH1A1 (0.50) | SLC6A4SLC6A2SLC6A3DPP4MAOA | |
| SCHEMBL3246807 | 0.79 | TACR1 (0.56) | SLC6A4MAOAMAOBTAAR1 | |
| SCHEMBL21899382 | 0.79 | SLC6A3 (0.42) | SLC6A4SLC6A2SLC6A3DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110437047-A | A kind of ethylcyclohexyl phenylalkyl ketone compound and preparation method thereof for display material | YANTAI FENGLU FINE CHEMICAL CO LTD | 2019-11-12 | — | — | CN | claimed |
| CN-101560396-B | Method for synthesizing fluorine-containing antiform alkyl cyclohexyl biphenyl single liquid crystal | LAIYANG SHENGHUA TECHNOLOGY CO LTD | 2012-07-25 | — | — | CN | claimed |
| CN-101560396-A | Method for synthesizing fluorine-containing antiform alkyl cyclohexyl biphenyl single liquid crystal | LAIYANG SHENGHUA TECHNOLOGY CO (CN) | 2009-10-21 | — | — | CN | claimed |
| US-7091290-B2 | Method for preparing homo-and co-polymers of cyclic olefin compounds using an organic boron compound as a catalyst activator | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2006-08-15 | — | — | US | claimed |
| CN-1201182-C | Liquid crystal display contg. chiral dopant | MERCK PATENT GMBH (DE) | 2005-05-11 | — | — | CN | claimed |
| CN-1420382-A | Liquid crystal display contg. chiral dopant | MERCK PATENT GMBH (DE) | 2003-05-28 | — | — | CN | claimed |
| EP-0444448-A2 | Phenylcyclohexylethane and liquid crystal medium | MERCK PATENT GmbH (DE) | 1991-09-04 | — | — | EP | claimed |
| US-10858298-B2 | Preparation of diphenyl compounds | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2020-12-08 | — | — | US | disclosed |
| US-10787399-B2 | Preparation and use of phenylstyrene | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-09-29 | — | — | US | disclosed |
| CN-110437047-A | A kind of ethylcyclohexyl phenylalkyl ketone compound and preparation method thereof for display material | YANTAI FENGLU FINE CHEMICAL CO LTD | 2019-11-12 | — | — | CN | disclosed |
| US-20190315665-A1 | PREPARATION OF DIPHENYL COMPOUNDS | EXXONMOBIL RES & ENG CO (US) | 2019-10-17 | — | — | US | disclosed |
| CN-110325522-A | Liquid crystal compounds | 默克专利股份有限公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-110023283-A | Sulfide compound | 默克专利股份有限公司 | 2019-07-16 | — | — | CN | disclosed |
| CN-1040024-A | 2, the 3-Difluorophenol derivatives | MERCK PATENT GMBH (DE) | 1990-02-28 | — | — | CN | disclosed |
| CN-1037334-A | Pyridine derivate | MERCK PATENT GMBH (DE) | 1989-11-22 | — | — | CN | disclosed |
| CN-1032435-A | The phenyl trifluoromethyl ethers that replaces | MERCK PATENT GMBH (DE) | 1989-04-19 | — | — | CN | disclosed |
| US-4802058-A | DISTILLATION, DEHYDROGENATION, DISTILLATION, AND HYDROGENATION | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1989-01-31 | — | — | US | disclosed |
| EP-0282013-A2 | Novel method for refining electrical insulating oil | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1988-09-14 | — | — | EP | disclosed |
| EP-0272580-A2 | Liquidcrystalline cyclohexylbenzene derivatives their manufacturing and novel nematic admixtures containing same | Wojskowa Akademia Techniczna im. Jaroslawa Dabrowskiego (PL) | 1988-06-29 | — | — | EP | disclosed |
| US-4371726-A | Composition suitable for mechanical power transmission and process for operating traction drives | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 1983-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190315665-A1 | PREPARATION OF DIPHENYL COMPOUNDS | DDT, PCBP1, BMI1 | SLC6A4 4510/4885SLC6A2 4682/4885SLC6A3 3874/4885 |
| US-10858298-B2 | Preparation of diphenyl compounds | DDT, PCBP1, BMI1 | SLC6A4 4510/4885SLC6A2 4682/4885SLC6A3 3874/4885 |
| US-10787399-B2 | Preparation and use of phenylstyrene | HPD, P4HB, PAH | SLC6A4 2221/4885SLC6A2 3348/4885SLC6A3 2516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.